Recurrent Angioedema (DBCOND0115806)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Lanadelumab A monoclonal antibody targeted against kallikrein which is used to treat attacks of hereditary angioedema.- Plasma kallikreintarget
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT03749135 Dupilumab in Chronic Spontaneous Urticaria treatment 2 completed